| abstract |
The invention relates to aminoalcohol-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one aminoalcoholsubstituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the aminoaleohol-substituted aryldihydroisoquinolinones of the invention and their derivatives as MCH antagonists. |